您当前所在位置:首页 > 资讯信息 > 科研动态
mPEG-PLGA-PLL载体用于EGF修饰顺铂纳米粒子构建
发布时间:2025-07-24     作者:kx   分享到:
期刊论文:顺铂阻抗EGF遮盖mPEG-PLGA-PLL纳米级激光束对小鼠SKOV3癌的致毒及*的功效联接://www.sciencedirect.com/science/article/abs/pii/S0142961212014135创作者:王云飞 a b 1,刘培峰 c 1,邱丽华 a b,孙英  ,朱明杰  ,顾丽英 a b,温迪   ,段 友容c节选:建立具备着低致毒和特喜欢的人*靶向治疗性的微米塑料颗粒具备着试炼性,还要粗略地装修设计微米塑料颗粒的組成、外形尺寸和生物学物理化学特征。这边光催化原理了表皮层产生指数(EGF)遮盖的甲氧基聚乙二醇-聚乳酸-无水乙醇酸-聚赖氨酸(mPEG-PLGA-PLL)包着的顺铂(CDDP)微米塑料颗粒(CDDP-NPs-EGF)以解决处理 CDDP 的致毒并延长*有效果率。CDDP-NPs-EGF 的看起来的特点是在身体外新增体组织致毒,这归因于有效果的体组织时间停滞不前和高体组织凋亡。在内部,CDDP-NPs-EGF 该变了中成药划分,调低了CDDP 的肾致毒,看起来延长了*有效果率,而就没有因起明星的系统致毒,认可了其在调低中成药致毒和怎强小鼠SKOV3 癌**有效果率管理方面的关键所在做用。

mPEG-PLGA-PLL

Construction on the nanoparticles with lower toxicity and specific tumor targeting properties is challenging and requires careful design of composition, size, physicochemical properties tailored for the nanoparticles. Here the epidermal growth factor (EGF) modified methoxy polyethylene glycol-polylactic-co-glycolic acid-polylysine (mPEG-PLGA-PLL) encapsulated cisplatin (CDDP) nanoparticles (CDDP-NPs-EGF) was prepared to for solving the toxicity of CDDP and improving therapeutic efficiency. The remarkable features of CDDP-NPs-EGF are increasing cytotoxicity that attribute to effective cell cycle arrest and high cell apoptosis in vitro. In vivo, the CDDP-NPs-EGF change drug distribution, decrease the nephrotoxicity of CDDP and improve significantly therapeutic efficiency without inducing obvious system toxicity, verifying its key role of the CDDP-NPs-EGF in lowering drug toxicity and enhancing the antitumor efficiency for SKOV3 cancer in mice.深圳pg电子娱乐游戏app 生物工程出具一些產品:PLL(20)-g[3.5]-PEG(2),多聚赖氨酸支链共聚聚乙二醇,Poly-L-lysine2500-g[3.5]-PEG88PLL(20)-g[5]-PEG(2)PLL(30)-g[3.5]-PEG(2)PLL(30)-g[5]-PEG(2)PLL(20)-g[3.5]-PEG(4)PLL(20)-g[5]-PEG(4)以下优秀文章信息原因多种论文期刊或论文资料,要是有侵犯著作权请沟通人们删除文件!